ダウンロード数: 1929

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
56_447.pdf2.97 MBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author関田, 信之ja
dc.contributor.author藤村, 正亮ja
dc.contributor.author新井, 寛子ja
dc.contributor.author柴田, 直樹ja
dc.contributor.author西川, 里佳ja
dc.contributor.author菅野, 勇ja
dc.contributor.author三上, 和男ja
dc.contributor.alternativeSekita, Nobuyukien
dc.contributor.alternativeFujimura, Masaakien
dc.contributor.alternativeArai, Hirokoen
dc.contributor.alternativeShibata, Naokien
dc.contributor.alternativeNishikawa, Rikaen
dc.contributor.alternativeSugano, Isamuen
dc.contributor.alternativeMikami, Kazuoen
dc.date.accessioned2010-09-01T09:16:14Z-
dc.date.available2010-09-01T09:16:14Z-
dc.date.issued2010-08-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/123564-
dc.description.abstractNo established treatment exists for urachal carcinoma, except curative resection, and its prognosis is poor. More than 80% of urachal carcinomas are adenocarcinomas. We report a case of advanced urachal carcinoma treated with S-1 and cisplatin combination (S-1/CDDP) chemotherapy. The patient, a 61-yearold woman, presented with macroscopic hematuria. A tumor was detected on the bladder dome and transurethral resection was performed. Histopathological findings indicated poorly differentiated adenocarcinoma. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels were 3.5 ng/ml and 140 U/ml respectively. Magnetic resonance images indicated an extension of this tumor to the retroperioneal space. Metastasis to her right ischium was suspected from bone scintigraphy results. The tumor was diagnosed as stage IVB (Sheldon's category) urachal carcinoma. After one cycle of S-1/CDDP chemotherapy, the size of the tumor on the bladder dome decreased, after which total cystectomy was performed. The surgical margin of the cystectomy specimen was negative for malignant cells, although poorly differentiated adenocarcinoma was still observed in this specimen. The findings of this study indicate that this therapy might be beneficial for treating advanced urachal carcinomas. This is the second report of successful treatment of advanced urachal carcinoma with S-1/CDDP chemotherapy.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher泌尿器科紀要刊行会ja
dc.rights許諾条件により本文は2011-09-01に公開ja
dc.subjectUrachal carcinoma, Chemotherapy, S-1, Cisplatinen
dc.subject.ndc494.9-
dc.titleS-1/CDDP 併用による化学療法が奏効した尿膜管癌の1例ja
dc.title.alternativeA Case of Urachal Carcinoma Treated with S-1/CDDP Combination Chemotherapyen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume56-
dc.identifier.issue8-
dc.identifier.spage447-
dc.identifier.epage451-
dc.textversionpublisher-
dc.sortkey05-
dc.address千葉県済生会習志野病院泌尿器科ja
dc.address千葉県済生会習志野病院泌尿器科ja
dc.address千葉県済生会習志野病院薬剤部ja
dc.address千葉県済生会習志野病院薬剤部ja
dc.address千葉県済生会習志野病院泌尿器科ja
dc.address千葉県済生会習志野病院病理部ja
dc.address千葉県済生会習志野病院泌尿器科ja
dc.startdate.bitstreamsavailable2011-09-01-
dc.address.alternativeThe Department of Urology, Chibaken Saiseikai Narashino Hospitalen
dc.address.alternativeThe Department of Urology, Chibaken Saiseikai Narashino Hospitalen
dc.address.alternativeThe Division of Pharmacy, Chibaken Saiseikai Narashino Hospitalen
dc.address.alternativeThe Division of Pharmacy, Chibaken Saiseikai Narashino Hospitalen
dc.address.alternativeThe Department of Urology, Chibaken Saiseikai Narashino Hospitalen
dc.address.alternativeThe Division of Pathology, Chibaken Saiseikai Narashino Hospitalen
dc.address.alternativeThe Department of Urology, Chibaken Saiseikai Narashino Hospitalen
dc.identifier.pmid20808064-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.56 No.8

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。